anonymous
Guest
anonymous
Guest
True investors look ahead, and they don’t panic with day-to-day gyrations of the stock. There is certainly potential for this to be $1 billion baby blockbuster, this is no secret. Big Pharma is starting to poke around the edges, keep following the big money as this is likely to be a buyout candidate over the next 12 to 18 months. The commercialization of the assets can be best accomplished with deeper pockets, although the company has really made some great strides to help push things ahead in the coming months.